Mylan Recalls Amlodipine and Valsartan Tablets Due to NDEA Impurity
Mylan Pharmaceuticals is recalling Amlodipine and Valsartan tablets because FDA testing found the impurity N-nitrosodiethylamine (NDEA) in the active ingredient.
- Product
- AMLODIPINE AND VALSARTAN — AMLODIPINE AND VALSARTAN (AMLODIPINE AND VALSARTAN)
- Category
- Drug
- Distribution
- 0 states